http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1986619-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b2af540ac9ae0e7630a250fbf284393 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2007-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a23c6fbf849a373ce5cad16cc4e4eb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8c676dafe96d981d101bc7251011e61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d6088d659c44727e03a0aac598d7b92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2913031e346bbd9abe519cd89233e5cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2581338124296bf3a6c94f15f50e188d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab388b529fce4958a4e2aa897da414f7 |
| publicationDate | 2008-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1986619-A2 |
| titleOfInvention | Use of phosphatases to treat tumors overexpressing n-cor |
| abstract | This invention provides a method of treating a patient suffering from a tumor overexpressing N-CoR comprising administering to the patient a phosphatase ligand, alone or in combination with 'a retinoid receptor ligand, a histone deacetylase ligand, or both, in amounts effective to treat the patient. This invention also provides a method of inhibiting tumor growth in a patient suffering from a tumor overexpressing N-CoR. This invention further provides a method of identifying a compound or a mixture of compounds capable of inducing differentiation of cells of a tumor overexpressing N- CoR. This invention still further provides a method of determining the likelihood of successfully treating a subject suffering from a tumor overexpressing N-CoR. This invention also provides a method of assessing the- likelihood that a patient is suffering from a tumor overexpressing N-CoR. This invention yet also provides a method of assessing the likelihood that a patient previously suffering from and treated for a tumor overexpressing N-CoR has suffered a recurrence of a tumor overexpressing N-CoR. Finally, this invention provides analogous methods for use on glioblastoma multiforme. |
| priorityDate | 2006-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 155.